InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ASTRAZENECA PLC

AZN Clue Score72
United Kingdom Fiscal year ends December CIK 0000901832
$159.20 +0.26% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $159.20 +161.84% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue23.00Operating income4.90Net income3.50EPS, diluted2.76Fiscal year 2017Revenue22.47 −2.3%Operating income3.68Net income3.00 −14.2%EPS, diluted2.37 −14.1%Fiscal year 2018Revenue22.09 −1.7%Operating income3.39Net income2.16 −28.2%EPS, diluted1.70 −28.3%Fiscal year 2019Revenue24.38 +10.4%Operating income2.92Net income1.34 −38.1%EPS, diluted1.03 −39.4%Fiscal year 2020Revenue26.62 +9.2%Operating income5.16Net income3.20 +139.4%EPS, diluted2.44 +136.9%Fiscal year 2021Revenue37.42 +40.6%Operating income1.06Net income0.11 −96.5%EPS, diluted0.08 −96.7%Fiscal year 2022Revenue44.35 +18.5%Operating income3.76Net income3.29 +2,835.7%EPS, diluted2.11 +2,537.5%Fiscal year 2023Revenue45.81 +3.3%Operating income8.19Net income5.96 +81.1%EPS, diluted3.81 +80.6%Fiscal year 2024Revenue54.07 +18.0%Operating income10.00Net income7.04 +18.1%EPS, diluted4.50 +18.1%Fiscal year 2025Revenue58.74 +8.6%Operating income13.74Net income10.23 +45.3%EPS, diluted6.54 +45.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 23.00 22.47 22.09 24.38 26.62 37.42 44.35 45.81 54.07 58.74
Growth −2.3% −1.7% +10.4% +9.2% +40.6% +18.5% +3.3% +18.0% +8.6%
Operating income 4.90 3.68 3.39 2.92 5.16 1.06 3.76 8.19 10.00 13.74
Net income 3.50 3.00 2.16 1.34 3.20 0.11 3.29 5.96 7.04 10.23
Growth −14.2% −28.2% −38.1% +139.4% −96.5% +2,835.7% +81.1% +18.1% +45.3%
EPS, diluted 2.76 2.37 1.70 1.03 2.44 0.08 2.11 3.81 4.50 6.54
Growth −14.1% −28.3% −39.4% +136.9% −96.7% +2,537.5% +80.6% +18.1% +45.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin82.1%Operating margin21.3%Net margin15.2%Free cash flow margin11.7%Fiscal year 2017Gross margin80.8%Operating margin16.4%Net margin13.4%Free cash flow margin10.0%Fiscal year 2018Gross margin77.7%Operating margin15.3%Net margin9.8%Free cash flow margin7.1%Fiscal year 2019Gross margin79.8%Operating margin12.0%Net margin5.5%Free cash flow margin8.2%Fiscal year 2020Gross margin80.1%Operating margin19.4%Net margin12.0%Free cash flow margin14.4%Fiscal year 2021Gross margin66.8%Operating margin2.8%Net margin0.3%Free cash flow margin13.0%Fiscal year 2022Gross margin72.1%Operating margin8.5%Net margin7.4%Free cash flow margin19.7%Fiscal year 2023Gross margin82.0%Operating margin17.9%Net margin13.0%Free cash flow margin19.6%Fiscal year 2024Gross margin81.1%Operating margin18.5%Net margin13.0%Free cash flow margin18.4%Fiscal year 2025Gross margin81.9%Operating margin23.4%Net margin17.4%Free cash flow margin20.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 82.1% 80.8% 77.7% 79.8% 80.1% 66.8% 72.1% 82.0% 81.1% 81.9%
Operating margin 21.3% 16.4% 15.3% 12.0% 19.4% 2.8% 8.5% 17.9% 18.5% 23.4%
Net margin 15.2% 13.4% 9.8% 5.5% 12.0% 0.3% 7.4% 13.0% 13.0% 17.4%
Free cash flow margin 11.7% 10.0% 7.1% 8.2% 14.4% 13.0% 19.7% 19.6% 18.4% 20.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow4.15Capital expenditure−1.45Free cash flow2.70Dividends paid−3.56Fiscal year 2017Operating cash flow3.58Capital expenditure−1.33Free cash flow2.25 −16.6%Dividends paid−3.52Fiscal year 2018Operating cash flow2.62Capital expenditure−1.04Free cash flow1.58 −30.1%Dividends paid−3.48Fiscal year 2019Operating cash flow2.97Capital expenditure−0.98Free cash flow1.99 +26.3%Dividends paid−3.59Fiscal year 2020Operating cash flow4.80Capital expenditure−0.96Free cash flow3.84 +92.9%Dividends paid−3.57Fiscal year 2021Operating cash flow5.96Capital expenditure−1.09Free cash flow4.87 +26.9%Buybacks−0.15Dividends paid−3.86Fiscal year 2022Operating cash flow9.81Capital expenditure−1.09Free cash flow8.72 +78.9%Dividends paid−4.36Fiscal year 2023Operating cash flow10.35Capital expenditure−1.36Free cash flow8.98 +3.1%Dividends paid−4.48Fiscal year 2024Operating cash flow11.86Capital expenditure−1.92Free cash flow9.94 +10.6%Buybacks−0.08Dividends paid−4.63Fiscal year 2025Operating cash flow14.58Capital expenditure−2.81Free cash flow11.77 +18.4%Buybacks−0.52Dividends paid−4.97
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 4.15 3.58 2.62 2.97 4.80 5.96 9.81 10.35 11.86 14.58
Capital expenditure −1.45 −1.33 −1.04 −0.98 −0.96 −1.09 −1.09 −1.36 −1.92 −2.81
Free cash flow 2.70 2.25 1.58 1.99 3.84 4.87 8.72 8.98 9.94 11.77
Growth −16.6% −30.1% +26.3% +92.9% +26.9% +78.9% +3.1% +10.6% +18.4%
Buybacks n/a n/a n/a n/a n/a −0.15 n/a n/a −0.08 −0.52
Dividends paid −3.56 −3.52 −3.48 −3.59 −3.57 −3.86 −4.36 −4.48 −4.63 −4.97

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash5.02Total debt14.50Net cash (debt)−9.48Shareholders’ equity14.85Debt to equity0.98Fiscal year 2017Cash3.32Total debt16.96Net cash (debt)−13.63Shareholders’ equity14.96Debt to equity1.13Fiscal year 2018Cash4.83Total debt18.36Net cash (debt)−13.53Shareholders’ equity12.47Debt to equity1.47Fiscal year 2019Cash5.37Total debt17.33Net cash (debt)−11.96Shareholders’ equity13.13Debt to equity1.32Fiscal year 2020Cash7.83Total debt19.04Net cash (debt)−11.21Shareholders’ equity15.62Debt to equity1.22Fiscal year 2021Cash6.33Total debt29.41Net cash (debt)−23.08Shareholders’ equity39.27Debt to equity0.75Fiscal year 2022Cash6.17Total debt27.93Net cash (debt)−21.76Shareholders’ equity37.04Debt to equity0.75Fiscal year 2023Cash5.84Total debt26.98Net cash (debt)−21.14Shareholders’ equity39.14Debt to equity0.69Fiscal year 2024Cash5.49Total debt28.51Net cash (debt)−23.03Shareholders’ equity40.79Debt to equity0.70Fiscal year 2025Cash5.71Total debt24.72Net cash (debt)−19.00Shareholders’ equity48.67Debt to equity0.51
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 5.02 3.32 4.83 5.37 7.83 6.33 6.17 5.84 5.49 5.71
Total debt 14.50 16.96 18.36 17.33 19.04 29.41 27.93 26.98 28.51 24.72
Net cash (debt) −9.48 −13.63 −13.53 −11.96 −11.21 −23.08 −21.76 −21.14 −23.03 −19.00
Shareholders’ equity 14.85 14.96 12.47 13.13 15.62 39.27 37.04 39.14 40.79 48.67
Debt to equity 0.98 1.13 1.47 1.32 1.22 0.75 0.75 0.69 0.70 0.51

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
23.00 22.47 22.09 24.38 26.62 37.42 44.35 45.81 54.07 58.74
Growth −2.3% −1.7% +10.4% +9.2% +40.6% +18.5% +3.3% +18.0% +8.6%
4.13 4.32 4.94 4.92 5.30 12.44 12.39 8.27 10.21 10.63
18.88 18.15 17.15 19.46 21.32 24.98 31.96 37.54 43.87 48.11
Growth −3.9% −5.5% +13.5% +9.5% +17.2% +27.9% +17.5% +16.8% +9.7%
5.89 5.76 5.93 6.06 5.99 9.74 9.76 10.94 13.58 14.23
9.41 10.23 10.03 11.68 11.29 15.23 18.42 19.22 19.98 19.93
4.90 3.68 3.39 2.92 5.16 1.06 3.76 8.19 10.00 13.74
Growth −25.0% −7.9% −13.7% +76.5% −79.5% +255.8% +118.1% +22.1% +37.4%
3.55 2.23 1.99 1.55 3.92 −0.27 2.50 6.90 8.69 12.40
0.15 −0.64 −0.06 0.32 0.77 −0.38 −0.79 0.94 1.65 2.17
3.50 3.00 2.16 1.34 3.20 0.11 3.29 5.96 7.04 10.23
Growth −14.2% −28.2% −38.1% +139.4% −96.5% +2,835.7% +81.1% +18.1% +45.3%
Per share
2.77 2.37 1.70 1.03 2.44 0.08 2.12 3.84 4.54 6.60
2.76 2.37 1.70 1.03 2.44 0.08 2.11 3.81 4.50 6.54
Growth −14.1% −28.3% −39.4% +136.9% −96.7% +2,537.5% +80.6% +18.1% +45.3%
1,265 1,266 1,267 1,301 1,312 1,418 1,548 1,549 1,550 1,550
1,266 1,267 1,267 1,301 1,313 1,427 1,560 1,562 1,563 1,562
Growth +0.1% +0.0% +2.7% +0.9% +8.7% +9.3% +0.1% +0.1% −0.1%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 17.2% a year over five years, and earnings per share grew 21.8% a year.
  • The diluted share count rose 19.0% in five years, which is dilution.
  • Operating margin is up 4.0 points on five years ago, at 23.4%.
  • Profitable in every one of the 10 years on file.